Home › Funds › WisdomTree › WisdomTree Global High Dividend Fund
Fund family: WisdomTree · Filed by WisdomTree Trust (CIK 1350487) · SEC series S000012397
Ticker: DEW (C000033635)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 9,053 with, 150 against, 12 abstentions (not counted as with management); 170 items carried no recommendation; 2 split votes are in neither count. Shareholder proposals: 65 FOR, 196 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as WisdomTree’s manager page (291,199 ballot items across 70 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | WisdomTree | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 92.6% | 7,508 | 91.6% | 236,396 |
| Backed environmental and social shareholder proposals at US companies | n/a | 26 | 0.1% | 1,437 |
Each ballot item this fund voted is set against the votes of the other WisdomTree funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most WisdomTree funds on all 8,016 items where a comparison was possible.
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 4,708 | 5 |
| Corporate Governance | 1,596 | 70 |
| Capital Structure | 994 | 0 |
| Compensation | 957 | 10 |
| Audit-related | 585 | 0 |
| Say-on-Pay | 251 | 0 |
| Extraordinary Transactions | 104 | 0 |
| Other | 78 | 0 |
| Environment or Climate | 51 | 44 |
| Other Social Issues | 42 | 13 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Exxon Mobil Corporation | May 27, 2026 | $4M | 17 | 2 |
| Chevron Corporation | May 27, 2026 | $3M | 17 | 3 |
| Johnson & Johnson | April 23, 2026 | $3M | 15 | 1 |
| AbbVie Inc. | May 8, 2026 | $2M | 8 | 1 |
| Merck & Co., Inc. | May 26, 2026 | $2M | 18 | 3 |
| Altria Group, Inc. | May 14, 2026 | $2M | 12 | 0 |
| Philip Morris International Inc. | May 6, 2026 | $2M | 13 | 1 |
| Gilead Sciences, Inc. | April 30, 2026 | $2M | 15 | 3 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 27, 2026 | Exxon Mobil Corporation | Independent Chair, a proposal overwhelmingly defeated on 16 separate occasions since 2000 Shareholder proposal | Against | For |
| May 27, 2026 | Exxon Mobil Corporation | Proposal requesting Company to modify its Voluntary Retail Voting Program to provide multiple options not aligned with the Board's recommendations Shareholder proposal | Against | For |
| May 27, 2026 | Chevron Corporation | Adopt an Independent Chair Shareholder proposal | Against | For |
| May 27, 2026 | Chevron Corporation | Report on Indigenous Peoples' Rights Shareholder proposal | Against | For |
| April 23, 2026 | Johnson & Johnson | Independent Board Chair Shareholder proposal | Against | For |
| May 8, 2026 | AbbVie Inc. | Stockholder Proposal - to Adopt a Policy to Require an Independent Chair Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposal | Against | For |
| May 26, 2026 | Merck & Co., Inc. | Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposal | Against | For |
| May 6, 2026 | Philip Morris International Inc. | Shareholder Proposal to issue a report on filter cleanup costs and extended producer responsibility laws for filters Shareholder proposal | Against | For |
| April 30, 2026 | Gilead Sciences, Inc. | To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| April 30, 2026 | Gilead Sciences, Inc. | To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposal | Against | For |
| April 16, 2026 | Texas Instruments Incorporated | Stockholder proposal to permit stockholders to act by written consent. Shareholder proposal | For | Against |
9,393 ballot items at 762 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, WisdomTree Global High Dividend Fund (DEW) voted at 762 shareholder meetings of 661 companies, on 9,393 ballot items in all. Where management made a recommendation, the fund followed it on 98.2% of the items and voted against it 150 times. Its most frequent area of disagreement was corporate governance (70 of its votes against management). It voted FOR 24.9% of the 261 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than WisdomTree's funds as a whole (92.6% against 91.6%). It voted the same way as most WisdomTree funds on every item where a comparison was possible.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of WisdomTree’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.